Fabian Tenenbaum

2017

In 2017, Fabian Tenenbaum earned a total compensation of $600.5K as Chief Executive Officer and former Chief Financial Officer at Bellerophon Therapeutics, a 57% decrease compared to previous year.

Compensation breakdown

Bonus$225,000
Salary$375,540
Total$600,540

Tenenbaum received $375.5K in salary, accounting for 63% of the total pay in 2017.

Tenenbaum also received $225K in bonus.

Rankings

In 2017, Fabian Tenenbaum's compensation ranked 11,193rd out of 14,666 executives tracked by ExecPay. In other words, Tenenbaum earned more than 23.7% of executives.

ClassificationRankingPercentile
All
11,193
out of 14,666
24th
Division
Manufacturing
4,379
out of 5,768
24th
Major group
Chemicals And Allied Products
1,587
out of 2,074
24th
Industry group
Drugs
1,306
out of 1,730
25th
Industry
Pharmaceutical Preparations
1,019
out of 1,329
23rd
Source: SEC filing on April 5, 2018.

Tenenbaum's colleagues

We found two more compensation records of executives who worked with Fabian Tenenbaum at Bellerophon Therapeutics in 2017.

2017

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

2017

Deborah Quinn

Bellerophon Therapeutics

Chief Medical Officer

News

You may also like